The asthma treatment market value will grow from approximately $15.9 billion in 2013 across eight major countries — the United States, United Kingdom, France, Germany, Spain, Italy, Japan and Australia — to $23.1 billion by 2023, according to research and consulting firm GlobalData.
The DIY beauty trend continues to show momentum, and according to industry sources, the at-home beauty devices segment is “pulsing with potential” as awareness among consumers continues to grow and new products hit the market.
Bayer HealthCare and HealthyWomen on Thursday launched the Family Size Matters initiative to help educate women who are done, or think they may be done, having children about their family planning, including permanent birth control.
Crest + Oral-B for Dental Professionals is celebrating its four registered dental hygienists Pros in the Profession award winners by sharing an exclusive grand prize trip to the Oral-B Innovation Center at Kronberg, Germany.
Women who use at-home skin care devices report high levels of satisfaction with these high-tech gadgets; however, the penetration rates remains largely because of a lack of awareness, according to new research by consulting and research firm Kline & Co.
Beiersdorf, whose brands include Nivea and Eucerin, announced that it is “very satisfied” with its first quarter business performance as the consumer business segment posted a 6.3% boost in organic sales during the quarter.
In a related transaction to Tuesday morning's acquisition of Merck's OTC portfolio, Bayer also agreed to enter into a strategic pharma collaboration in the area of cardiovascular diseases with a focus on sGC modulation.
The epilepsy therapeutics market value in the eight major countries — the United States, Canada, France, Germany, Italy, Spain, the United Kingdom and Japan — will increase from $3.4 billion in 2012 to $4.5 billion by 2019, at a compound annual growth rate of 3.9%, according to a new report from business intelligence provider GBI Research.